Patent · US Active

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

US9782474B2 · kind B2 · utility

2Cited by
46References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 23, 2011
Grant dateOct 10, 2017
Priority date—
Expiry dateNov 23, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16634
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2, which can be used therapeutically or prophylactically, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.